logo
episode-header-image
Jan 2024
35m 40s

Episode 104: Jewelry, Insurance and the ...

Rapaport
About this episode

Dustin Lemick, founder and CEO of insurance technology company BriteCo, shares his insights on the recent festive shopping season in a conversation we recorded on December 20. Plus: How lab-grown pricing impacts insurance. 

Up next
Mar 1
Episode 158: Face Recognition for Diamonds
Mayank Jain, CEO of DiaDNA, outlines how the company is developing technology to identify diamonds and prevent stone-switching. Mayank explains the difference between optical and atomic scanning and how the industry can benefit from the extra traceability.You can watch this episo ... Show More
32m 59s
Feb 18
Episode 157: How India Has Come to Love Diamonds
Richa Singh, managing director for India and the Middle East at the Natural Diamond Council (NDC), explains the rise of one of the world’s fastest-growing diamond markets. Plus: What the US-India trade deal might mean, the lab-grown sector’s expansion, and how jewelers use WhatsA ... Show More
44m 56s
Jan 28
Episode 156: Lobbying Washington on Tariffs
John Ford, CEO of the American Gem Trade Association (AGTA), and Bruce Bridges, its president, report on talks with US government officials over potential tariff relief. Plus: How colored gemstones have staved off competition from synthetics. 
41m 15s
Recommended Episodes
Jun 2024
E57: Nat Scopelliti-The Insurance Guy
<div class="dashboard --banner"> <div class="side"> <div id="conversation-sidebar" class="conversation-meeting-notes"> <div class="conversation-meeting-notes__scroll-container"> <div class="_meetingChat_h3a6v_1"> <div class="_messageList_fo4jx_1 _scrollbar_1pg6a_1" tabindex="0" d ... Show More
32m 54s
Jun 2020
PIR 199 - The Future of Insurance by Bryan Falchuk
<p>Tony interviews Bryan Falchuk about his upcoming book &quot;The Future of Insurance: From Disruption to Evolution&quot; which comes out June 24th. Bryan interviewed leaders at seven leading carriers about innovations projects that succeeded even against the obstacles of techno ... Show More
47m 27s
Sep 2020
Eli Lilly CEO, Coca Cola CEO & Albertsons CEO
<p>The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's pr ... Show More
46m 19s
Mar 2024
Exposing Hidden Costs: The Truth Behind Your Insurance Excess
In this practical episode of My Money My Lifestyle, host Maya Fisher-French tackles the often-overlooked details of short-term insurance contracts that can have a big impact on your wallet. Maya shares her personal discovery of significant hikes in her insurance policy when it ca ... Show More
22m 29s
Aug 2021
The Chinese Stock Rally and the Cathie Wood Effect, Mandates and the Reopening Trade After Full Approval of Pfizer's COVID Vaccine, Boeing Faces New Scrutiny, Tim Cook's Decade as CEO of Apple, and the CEO of Medtronic Talks Earnings and the Pandemic.
Carl Quintanilla, Jim Cramer and David Faber explored the reasons behind a big rally in shares of China-based companies. One of the catalysts: Cathie Wood's Ark Invest buying almost 165,000 shares of JD.com. The reopening trade very much in focus one day after the FDA fully appro ... Show More
44m 6s
Nov 2023
The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond. Learn more about your ad choices. Visit megaphone.fm/adchoices 
26m 30s